Hapvida May Push Up Individual Health Plan Premiums in Brazil
Inclusion of the operator in the regulator’s calculation could lift adjustments to as much as 7.8%.
Inclusion of the operator in the regulator’s calculation could lift adjustments to as much as 7.8%.
Operator raised revenue and average ticket, but higher care costs and a smaller beneficiary base kept margins under heavy pressure.
Bradesco Saúde and Amil lead monthly gains while Hapvida posts the largest decline as Brazil’s private insurance sector starts 2026 in contraction.
Revenue climbs 12% year-on-year while EBITDA reaches R$455.9 million, supported by B2C expansion and acquisitions.